These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32204324)

  • 41. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
    Rethwilm A
    Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in Gene Therapy for Fanconi Anemia.
    Río P; Navarro S; Bueren JA
    Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficient liver gene transfer with foamy virus vectors.
    Zacharoulis D; Rountas C; Katsimpoulas M; Morianos J; Chatziandreou I; Vassilopoulos G
    Med Sci Monit Basic Res; 2013 Aug; 19():214-20. PubMed ID: 23941977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adeno-associated virus-mediated gene transfer in hematopoietic stem/ progenitor cells as a therapeutic tool.
    Zhong L; Zhao W; Wu J; Maina N; Han Z; Srivastava A
    Curr Gene Ther; 2006 Dec; 6(6):683-98. PubMed ID: 17168699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
    Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic manipulation of primate embryonic and hematopoietic stem cells with simian lentivirus vectors.
    Hanazono Y; Asano T; Ueda Y; Ozawa K
    Trends Cardiovasc Med; 2003 Apr; 13(3):106-10. PubMed ID: 12691674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hematopoietic stem cell gene therapy.
    Emery DW; Nishino T; Murata K; Fragkos M; Stamatoyannopoulos G
    Int J Hematol; 2002 Apr; 75(3):228-36. PubMed ID: 11999349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Foamy virus vectors for HIV gene therapy.
    Olszko ME; Trobridge GD
    Viruses; 2013 Oct; 5(10):2585-600. PubMed ID: 24153061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Foamy virus as a gene transfer vector to the central nervous system.
    Caprariello AV; Miller RH; Selkirk SM
    Gene Ther; 2009 Mar; 16(3):448-52. PubMed ID: 19052632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
    Horino S; Uchiyama T; So T; Nagashima H; Sun SL; Sato M; Asao A; Haji Y; Sasahara Y; Candotti F; Tsuchiya S; Kure S; Sugamura K; Ishii N
    PLoS One; 2013; 8(8):e71594. PubMed ID: 23990961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Development of gene therapy for hematopoietic stem cell using viral vectors].
    Dong WJ; Zu ZX; Liu DP; Liang CC
    Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
    Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
    Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors.
    Josephson NC; Vassilopoulos G; Trobridge GD; Priestley GV; Wood BL; Papayannopoulou T; Russell DW
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8295-300. PubMed ID: 12060773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Foamy virus for efficient gene transfer in regeneration studies.
    Khattak S; Sandoval-Guzmán T; Stanke N; Protze S; Tanaka EM; Lindemann D
    BMC Dev Biol; 2013 May; 13():17. PubMed ID: 23641815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transduction of umbilical cord blood CD34+ NOD/SCID-repopulating cells by simian foamy virus type 1 (SFV-1) vector.
    Zucali JR; Ciccarone T; Kelley V; Park J; Johnson CM; Mergia A
    Virology; 2002 Oct; 302(2):229-35. PubMed ID: 12441067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic manipulation of hematopoietic stem cells.
    Larochelle A; Dunbar CE
    Semin Hematol; 2004 Oct; 41(4):257-71. PubMed ID: 15508111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of nonhuman primate models to improve gene transfer into haematopoietic stem cells.
    Dunbar CE
    J Intern Med; 2001 Apr; 249(4):329-38. PubMed ID: 11298853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.
    Cornils K; Lange C; Schambach A; Brugman MH; Nowak R; Lioznov M; Baum C; Fehse B
    Mol Ther; 2009 Jan; 17(1):131-43. PubMed ID: 19002163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
    Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
    Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.